ATLAS Biolabs
ATLAS Biolabs is a leading European service provider specializing in molecular genetic analyses, diagnostics, and complex bioinformatics data analyses. They offer a wide range of services including next-generation sequencing, microarray analyses, digital karyotyping, mutation analyses, and more, serving research institutions, clinics, pharmaceutical and biotech companies, and medical professionals. Their mission is to provide high-quality, reliable, and flexible genetic testing and analysis services to support scientific research and personalized medicine.
Industries
Nr. of Employees
small (1-50)
ATLAS Biolabs
Aroser Allee 68, 13407 Berlin, Germany
Services
Analysis pipelines and delivery of processed NGS data for WGS, WES and RNA-seq projects including QC, alignment, variant calling and annotation.
Normalization and statistical analysis of microarray datasets with QC graphics, annotated tables and publication-ready reports.
RNA sequencing and microarray-based transcriptome analyses including exon-level and isoform detection, differential expression and gene fusion detection.
High-resolution microarray-based cytogenetic analyses for detection of CNVs, LOH and chromosomal aberrations with delivery of original data and QC reports.
Analysis of FFPE-derived DNA for cancer gene profiling, somatic mutation detection and genome-wide CNV/LOH analysis with lists of putative aberrations and quality reports.
Genome-wide and pharmacogenetic genotyping services for ADME-relevant markers with genotype export in common formats for downstream analysis.
Analysis pipelines and delivery of processed NGS data for WGS, WES and RNA-seq projects including QC, alignment, variant calling and annotation.
Normalization and statistical analysis of microarray datasets with QC graphics, annotated tables and publication-ready reports.
RNA sequencing and microarray-based transcriptome analyses including exon-level and isoform detection, differential expression and gene fusion detection.
High-resolution microarray-based cytogenetic analyses for detection of CNVs, LOH and chromosomal aberrations with delivery of original data and QC reports.
Analysis of FFPE-derived DNA for cancer gene profiling, somatic mutation detection and genome-wide CNV/LOH analysis with lists of putative aberrations and quality reports.
Genome-wide and pharmacogenetic genotyping services for ADME-relevant markers with genotype export in common formats for downstream analysis.
Expertise Areas
- NGS data analysis
- Transcriptomics and exon-level expression analysis
- Microarray data analysis and statistical reporting
- Genotyping and pharmacogenetics
Key Technologies
- Whole-genome sequencing (WGS)
- Whole-exome sequencing (WES)
- RNA sequencing (RNA-seq)
- ChIP sequencing (ChIP-seq)
News & Updates
A study investigating the role of genetic factors in the course of SARS-CoV-2 infection, focusing on membrane proteins ACE2 and TMPRSS2, funded by the German Federal Ministry of Education and Research.
A publication evaluating HPV DNA as biomarkers for recurrent CIN2/3 post-treatment.
A study on risk prediction using genetic and clinical parameters.
A comprehensive study on genetic causes of hereditary nonsyndromic hearing loss.
A study investigating the role of genetic factors in the course of SARS-CoV-2 infection, focusing on membrane proteins ACE2 and TMPRSS2, funded by the German Federal Ministry of Education and Research.
A publication evaluating HPV DNA as biomarkers for recurrent CIN2/3 post-treatment.
A study on risk prediction using genetic and clinical parameters.
A comprehensive study on genetic causes of hereditary nonsyndromic hearing loss.